Bill & Melinda Gates Foundation: Grand Challenge for Innovations in Vaccine Manufacturing

Last date : November 5, 2015

 

 

The Bill & Melinda Gates Foundation is inviting applicants for its new Grand Challenge, innovations in Vaccine Manufacturing for Global Markets. This challenge focuses on innovations in vaccine manufacturing platforms designed to lower production cost for vaccines that target diseases of great global burden and that are among the most costly to produce with current technologies. The number of awards and quantity of each award amount will depend upon the quality of the proposals received.

The Foundation is soliciting proposals to develop manufacturing platforms that can transform vaccine production economics and produce vaccines at a final finished goods production cost of ≤ $0.15 per dose.

 

Eligibility Criteria

• Grand Challenges is open to both foreign and domestic organizations, including non-profit organizations, for-profit companies, international organizations, government agencies and academic institutions. Individuals and organizations classified as individuals for U.S. tax purposes (including sole proprietorships and some single member limited liability companies) are not eligible to receive an award as part of the Grand Challenges initiative from the foundation.
• The foundation expects that program goals for this Grand Challenge may be met by applicants intending to perform fundamental research, i.e., basic or applied research, the results of which ordinarily are published and shared broadly within the scientific community and made available consistent with Global Access.

 

How to Apply

Applicants may register and apply from the official website, given at the end.

 

For more details : http://gcgh.grandchallenges.org/challenge/new-interventions-global-health-vaccine-manufacturing

Share this

Unknown